行业洗牌加速,MNC何以自处?强生、罗氏、赛诺菲年报揭示差异化增长路径

医药经济报
Yesterday

药企“年终大考”成绩单陆续揭晓!强生、罗氏、赛诺菲等巨头近日率先发布2025年全年业绩,全球制药行业新格局初现端倪。强生本年度营收近942亿美元,罗氏制药业务增速强劲,赛诺菲更是以近10%的增速成为“增长之星”。在行业剧烈分化的背景下,巨头们的战略选择与增长路径,正成为观察制药产业未来走向的关键窗口。三巨头增长路径分野在2025年,强生、罗氏、赛诺菲这三家医药行业巨头呈现出截然不同的增长路径,这...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10